Immune checkpoint inhibitors, a class of immunotherapies that help immune cells attack cancer more effectively, have revolutionized cancer treatment. However, fewer than 20% of patients respond to ...

Researchers from Touro University and Lovelace Biomedical are Developing an Innovative Treatment for Lung Cancer ...

The following is a summary of “Mediating effects of coping strategies between symptom clusters and quality of life in lung ...

Pulmonary sarcoidosis is a lung disease characterized by granulomas—tiny clumps of immune cells that form in response to ...

The US Food and Drug Administration (FDA) has granted clearance to CureVac's investigational new drug application (IND) for the open-label Phase I trial of CVHNLC in individuals with squamous ...